أعاد TWAS-AREP : The World Academy of Sciences’ Arab Regional Partner نشر هذا
The idea of using blood or plasma from convalescent patients to protect or treat newly infected ones is centuries old; however, its efficacy is still questionable. Now that the technology can allow the design and production of highly specific antibodies, we are back to the old question: Can our antibodies be used to treat emerging infectious diseases, especially when they are untreatable or resistant to every existing treatment? The November Webinar of the "Remedy Within" series hosts two of the world's top immunologists: Dr. Ali Ellebedy (from Washington University, St. Louis, USA) will talk about "Immunity to Influenza Viruses: Catching a Moving Target.” Dr. Emanuele Andreano (from Toscana Life Sciences Foundation, Siena, Italy) will discuss: "The Original Antigenic Sin: lessons learned from the COVID-19 pandemic" Register to the November 18th webinar, which will be held at 7 PM, Cairo Time by following this link: https://lnkd.in/dp9q5Ndr